NCT06133257

Brief Summary

Controlling the amount of fluids given to patients in perioperative setting can significantly influence their outcomes.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 15, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

November 15, 2023

Status Verified

November 1, 2023

Enrollment Period

7 months

First QC Date

October 31, 2023

Last Update Submit

November 10, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Mean Arterial Blood Pressure

    intraoperative mean arterial blood pressure measured in mmHg

    intraoperatively every 5 minutes

  • Quality of Recovery-40 score(QoR-40)

    QoR-40 score ranges from 40 to 200, the higher the score the better the outcome

    24 hours postoperative

  • Heart Rate

    intraoperative heart rate will be continuously monitored and recorded every 5 minutes

    intraoperatively every 5 minutes

  • Post Anesthesia Care Unit(PACU) Stay

    time spent in PACU after surgery measured in minutes

    2 hours postoperatively

Secondary Outcomes (4)

  • Total fluid intake during operation

    intraoperatively

  • Number of patients that needed Ephedrine or Atropine

    intraoperatively

  • Peripheral perfusion index

    Intraoperatively

  • Length of hospital stay

    the patient will be followed up for 60 days from day of surgery

Study Arms (2)

GD Group

ACTIVE COMPARATOR

Patients will take oral clear fluids with carbohydrates content 2 hours preoperatively and intraoperative fluid intake will be guided by Inferior vena cava(IVC) diameter.

Procedure: Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index

C Group

ACTIVE COMPARATOR

the standard fluid management group patients will be fasting 6 hours preoperatively and will receive intraoperative fluid in standard manner.

Procedure: standard fluid management

Interventions

Measuring Inferior vena cava(IVC) diameter using ultrasound then calculation Inferior vena cava(IVC) collapsibility index and administer fluid accordingly.

GD Group

standard fluid management

C Group

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient's acceptance.
  • Patients planned for elective lower limb surgery under spinal anesthesia.
  • Both sexes
  • Body Mass Index(BMI): \<35
  • Age: 21 \~ 65 years
  • American Society of Anesthesiologists(ASA) Physical Status Classification System: Class I \& II
  • Duration of surgery 2\~3 hours

You may not qualify if:

  • Advanced kidney, liver, respiratory or cardiovascular disease.
  • Contraindication for spinal anesthesia.
  • Patients shifted to general anesthesia for any reason.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

EdemaHypovolemiaShock, Surgical

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsPathologic ProcessesPostoperative ComplicationsShock

Study Officials

  • Mahmoud Abdelkader, MBBCh

    Anesthesia, Intensive Care and Pain Management department, Faculty of Medicine, Zagazig University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mahmoud Abdelkader, MBBCh

CONTACT

Alshaimaa Kamel, MD.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor of anesthesia, Intensive Care and Pain Management

Study Record Dates

First Submitted

October 31, 2023

First Posted

November 15, 2023

Study Start

December 1, 2023

Primary Completion

July 1, 2024

Study Completion

August 1, 2024

Last Updated

November 15, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share